Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Esteban G. Burchard is active.

Publication


Featured researches published by Esteban G. Burchard.


Journal of Clinical Investigation | 2007

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

Yan Shu; Steven A. Sheardown; Chaline Brown; Ryan P. Owen; Shuzhong Zhang; Richard A. Castro; Alexandra G. Ianculescu; Lin Yue; Joan C. Lo; Esteban G. Burchard; Claire M. Brett; Kathleen M. Giacomini

Metformin is among the most widely prescribed drugs for the treatment of type 2 diabetes. Organic cation transporter 1 (OCT1) plays a role in the hepatic uptake of metformin, but its role in the therapeutic effects of the drug, which involve activation of AMP-activated protein kinase (AMPK), is unknown. Recent studies have shown that human OCT1 is highly polymorphic. We investigated whether OCT1 plays a role in the action of metformin and whether individuals with OCT1 polymorphisms have reduced response to the drug. In mouse hepatocytes, deletion of Oct1 resulted in a reduction in the effects of metformin on AMPK phosphorylation and gluconeogenesis. In Oct1-deficient mice the glucose-lowering effects of metformin were completely abolished. Seven nonsynonymous polymorphisms of OCT1 that exhibited reduced uptake of metformin were identified. Notably, OCT1-420del (allele frequency of about 20% in white Americans), previously shown to have normal activity for model substrates, had reduced activity for metformin. In clinical studies, the effects of metformin in glucose tolerance tests were significantly lower in individuals carrying reduced function polymorphisms of OCT1. Collectively, the data indicate that OCT1 is important for metformin therapeutic action and that genetic variation in OCT1 may contribute to variation in response to the drug.


Nature Genetics | 2011

Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations

Dara G. Torgerson; Elizabeth J. Ampleford; Grace Y. Chiu; W. James Gauderman; Christopher R. Gignoux; Penelope E. Graves; Blanca E. Himes; A. Levin; Rasika A. Mathias; Dana B. Hancock; James W. Baurley; Celeste Eng; Debra A. Stern; Juan C. Celedón; Nicholas Rafaels; Daniel Capurso; David V. Conti; Lindsey A. Roth; Manuel Soto-Quiros; Alkis Togias; Xingnan Li; Rachel A. Myers; Isabelle Romieu; David Van Den Berg; Donglei Hu; Nadia N. Hansel; Ryan D. Hernandez; Elliott Israel; Muhammad T. Salam; Joshua M Galanter

Asthma is a common disease with a complex risk architecture including both genetic and environmental factors. We performed a meta-analysis of North American genome-wide association studies of asthma in 5,416 individuals with asthma (cases) including individuals of European American, African American or African Caribbean, and Latino ancestry, with replication in an additional 12,649 individuals from the same ethnic groups. We identified five susceptibility loci. Four were at previously reported loci on 17q21, near IL1RL1, TSLP and IL33, but we report for the first time, to our knowledge, that these loci are associated with asthma risk in three ethnic groups. In addition, we identified a new asthma susceptibility locus at PYHIN1, with the association being specific to individuals of African descent (P = 3.9 × 10−9). These results suggest that some asthma susceptibility loci are robust to differences in ancestry when sufficiently large samples sizes are investigated, and that ancestry-specific associations also contribute to the complex genetic architecture of asthma.


Clinical Pharmacology & Therapeutics | 2008

Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin Pharmacokinetics

Y Shu; Chaline Brown; Richard A. Castro; Rj Shi; Emil T. Lin; Ryan P. Owen; Sa Sheardown; L Yue; Esteban G. Burchard; Claire M. Brett; Kathleen M. Giacomini

The goal of this study was to determine the effects of genetic variation in the organic cation transporter 1, OCT1, on the pharmacokinetics of the antidiabetic drug, metformin. Twenty healthy volunteers with known OCT1 genotype agreed to participate in the study. Each subject received two oral doses of metformin followed by collection of blood and urine samples. OCT1 genotypes had a significant (P<0.05) effect on metformin pharmacokinetics, with a higher area under the plasma concentration–time curve (AUC), higher maximal plasma concentration (Cmax), and lower oral volume of distribution (V/F) in the individuals carrying a reduced function OCT1 allele (R61C, G401S, 420del, or G465R). The effect of OCT1 on metformin pharmacokinetics in mice was less than in humans possibly reflecting species differences in hepatic expression level of the transporter. Our studies suggest that OCT1 genotype is a determinant of metformin pharmacokinetics.


American Journal of Public Health | 2005

Latino Populations: A Unique Opportunity for the Study of Race, Genetics, and Social Environment in Epidemiological Research

Esteban G. Burchard; Luisa N. Borrell; Shweta Choudhry; Mariam Naqvi; Hui Ju Tsai; Jose R. Rodriguez-Santana; Rocio Chapela; Scott D. Rogers; Rui Mei; William Rodriguez-Cintron; Jose F. Arena; Rick A. Kittles; Eliseo J. Pérez-Stable; Elad Ziv; Neil Risch

Latinos are the largest minority population in the United States. Although usually classified as a single ethnic group by researchers, Latinos are heterogeneous from cultural, socioeconomic, and genetic perspectives. From a cultural and social perspective, Latinos represent a wide variety of national origins and ethnic and cultural groups, with a full spectrum of social class. From a genetic perspective, Latinos are descended from indigenous American, European, and African populations. We review the historical events that led to the formation of contemporary Latino populations and use results from recent genetic and clinical studies to illustrate the unique opportunity Latino groups offer for studying the interaction between racial, genetic, and environmental contributions to disease occurrence and drug response.


Nature | 2011

Genomics for the world

Carlos Bustamante; Francisco M. De La Vega; Esteban G. Burchard

Medical genomics has focused almost entirely on those of European descent. Other ethnic groups must be studied to ensure that more people benefit, say Carlos D. Bustamante, Esteban Gonzalez Burchard and Francisco M. De La Vega.


Circulation-cardiovascular Genetics | 2010

Ethical and Practical Guidelines for Reporting Genetic Research Results to Study Participants: Updated Guidelines From a National Heart, Lung, and Blood Institute Working Group

Richard R. Fabsitz; Amy L. McGuire; Richard R. Sharp; Mona A. Puggal; Laura M. Beskow; Leslie G. Biesecker; Ebony Bookman; Wylie Burke; Esteban G. Burchard; George M. Church; Ellen Wright Clayton; John H. Eckfeldt; Conrad V. Fernandez; Rebecca Fisher; Stephanie M. Fullerton; Stacey Gabriel; Francine C. Gachupin; Cynthia A. James; Gail P. Jarvik; Rick A. Kittles; Jennifer R. Leib; Christopher J. O'Donnell; P. Pearl O'Rourke; Laura Lyman Rodriguez; Sheri D. Schully; Alan R. Shuldiner; Rebecca K.F. Sze; Joseph V. Thakuria; Susan M. Wolf; Gregory L. Burke

In January 2009, the National Heart, Lung, and Blood Institute convened a 28-member multidisciplinary Working Group to update the recommendations of a 2004 National Heart, Lung, and Blood Institute Working Group focused on Guidelines to the Return of Genetic Research Results. Changes in the genetic and societal landscape over the intervening 5 years raise multiple questions and challenges. The group noted the complex issues arising from the fact that technological and bioinformatic progress has made it possible to obtain considerable information on individuals that would not have been possible a decade ago. Although unable to reach consensus on a number of issues, the working group produced 5 recommendations. The working group offers 2 recommendations addressing the criteria necessary to determine when genetic results should and may be returned to study participants, respectively. In addition, it suggests that a time limit be established to limit the duration of obligation of investigators to return genetic research results. The group recommends the creation of a central body, or bodies, to provide guidance on when genetic research results are associated with sufficient risk and have established clinical utility to justify their return to study participants. The final recommendation urges investigators to engage the broader community when dealing with identifiable communities to advise them on the return of aggregate and individual research results. Creation of an entity charged to provide guidance to institutional review boards, investigators, research institutions, and research sponsors would provide rigorous review of available data, promote standardization of study policies regarding return of genetic research results, and enable investigators and study participants to clarify and share expectations for the handling of this increasingly valuable information with appropriate respect for the rights and needs of participants.


American Journal of Respiratory and Critical Care Medicine | 2008

ORMDL3 gene is associated with asthma in three ethnically diverse populations.

Joshua M. Galanter; Shweta Choudhry; Celeste Eng; Sylvette Nazario; Jose R. Rodriguez-Santana; Jesus Casal; Alfonso Torres-Palacios; Jorge Salas; Rocio Chapela; H. Geoffrey Watson; Kelley Meade; Michael LeNoir; William Rodríguez-Cintrón; Pedro C. Avila; Esteban G. Burchard

RATIONALE Independent replication of genetic associations in complex diseases, particularly in whole-genome association studies, is critical to confirm the association. OBJECTIVES A whole-genome association study identified ORMDL3 as a promising candidate gene for asthma in white populations. Here, we attempted to confirm the role of ORMDL3 genetic variants in asthma in three ethnically diverse populations: Mexican, Puerto Rican, and African American. METHODS We used family-based analyses to test for association between seven candidate single-nucleotide polymorphisms (SNPs) in and around the ORMDL3 gene and asthma and related phenotypes in 701 Puerto Rican and Mexican parent-child trios. We also evaluated these seven SNPs and an additional ORMDL3 SNP in 264 African American subjects with asthma and 176 healthy control subjects. MEASUREMENTS AND MAIN RESULTS We found significant associations between two SNPs within ORMDL3 (rs4378650 and rs12603332) and asthma in Mexicans and African Americans (P = 0.028 and 0.001 for rs4378650 and P = 0.021 and 0.001 for rs12603332, respectively), and a trend toward association in Puerto Ricans (P = 0.076 and 0.080 for SNPs rs4378650 and rs12603332, respectively). These associations became stronger among Mexican and Puerto Rican subjects with asthma with IgE levels greater than 100 IU/ml. We did not find any association between ORMDL3 SNPs and baseline lung function or response to the bronchodilator albuterol. CONCLUSIONS Our results confirm that the ORMDL3 locus is a risk factor for asthma in ethnically diverse populations. However, inconsistent SNP-level results suggest that further studies will be needed to determine the mechanism by which ORMDL3 predisposes to asthma.


Human Genetics | 2006

Population stratification confounds genetic association studies among Latinos

Shweta Choudhry; Natasha E. Coyle; Hua Tang; Keyan Salari; Denise L. Lind; Suzanne Clark; Hui Ju Tsai; Mariam Naqvi; Angie Phong; Ngim Ung; Henry Matallana; Pedro C. Avila; Jesus Casal; Alfonso Torres; Sylvette Nazario; Richard A. Castro; Natalie C. Battle; Eliseo J. Pérez-Stable; Pui-Yan Kwok; Dean Sheppard; Mark D. Shriver; William Rodriguez-Cintron; Neil Risch; Elad Ziv; Esteban G. Burchard

In the United States, asthma prevalence and mortality are the highest among Puerto Ricans and the lowest among Mexicans. Case-control association studies are a powerful strategy for identifying genes of modest effect in complex diseases. However, studies of complex disorders in admixed populations such as Latinos may be confounded by population stratification. We used ancestry informative markers (AIMs) to identify and correct for population stratification among Mexican and Puerto Rican subjects participating in case-control studies of asthma. Three hundred and sixty-two subjects with asthma (Mexican: 181, Puerto Rican: 181) and 359 ethnically matched controls (Mexican: 181, Puerto Rican: 178) were genotyped for 44 AIMs. We observed a greater than expected degree of association between pairs of AIMs on different chromosomes in Mexicans (P<0.00001) and Puerto Ricans (P<0.00002) providing evidence for population substructure and/or recent admixture. To assess the effect of population stratification on association studies of asthma, we measured differences in genetic background of cases and controls by comparing allele frequencies of the 44 AIMs. Among Puerto Ricans but not in Mexicans, we observed a significant overall difference in allele frequencies between cases and controls (P=0.0002); of 44 AIMs tested, 8 (18%) were significantly associated with asthma. However, after adjustment for individual ancestry, only two of these markers remained significantly associated with the disease. Our findings suggest that empirical assessment of the effects of stratification is critical to appropriately interpret the results of case-control studies in admixed populations.


Science | 2014

The genetics of Mexico recapitulates Native American substructure and affects biomedical traits

Andres Moreno-Estrada; Christopher R. Gignoux; Juan Carlos Fernández-López; Fouad Zakharia; Martin Sikora; Alejandra V. Contreras; Victor Acuña-Alonzo; Karla Sandoval; Celeste Eng; Sandra Romero-Hidalgo; Patricia Ortiz-Tello; Victoria Robles; Eimear E. Kenny; Ismael Nuño-Arana; Rodrigo Barquera-Lozano; Gastón Macín-Pérez; Julio Granados-Arriola; Scott Huntsman; Joshua M. Galanter; Marc Via; Jean G. Ford; Rocio Chapela; William Rodriguez-Cintron; Jose R. Rodriguez-Santana; Isabelle Romieu; Juan José Luis Sienra-Monge; Blanca Estela del Río Navarro; Stephanie J. London; Andres Ruiz-Linares; Rodrigo García-Herrera

The population structure of Native Mexicans The genetics of indigenous Mexicans exhibit substantial geographical structure, some as divergent from each other as are existing populations of Europeans and Asians. By performing genome-wide analyses on Native Mexicans from differing populations, Moreno-Estrada et al. successfully recapitulated the pre-Columbian substructure of Mexico. This ancestral structure is evident among cosmopolitan Mexicans and is correlated with subcontinental origins and medically relevant aspects of lung function. These findings exemplify the importance of understanding the genetic contributions of admixed individuals. Science, this issue p. 1280 Indigenous and cosmopolitan Mexican populations are highly structured with genetic variation of medical relevance. Mexico harbors great cultural and ethnic diversity, yet fine-scale patterns of human genome-wide variation from this region remain largely uncharacterized. We studied genomic variation within Mexico from over 1000 individuals representing 20 indigenous and 11 mestizo populations. We found striking genetic stratification among indigenous populations within Mexico at varying degrees of geographic isolation. Some groups were as differentiated as Europeans are from East Asians. Pre-Columbian genetic substructure is recapitulated in the indigenous ancestry of admixed mestizo individuals across the country. Furthermore, two independently phenotyped cohorts of Mexicans and Mexican Americans showed a significant association between subcontinental ancestry and lung function. Thus, accounting for fine-scale ancestry patterns is critical for medical and population genetic studies within Mexico, in Mexican-descent populations, and likely in many other populations worldwide.


The Journal of Allergy and Clinical Immunology | 2011

Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence.

L. Keoki Williams; Edward L. Peterson; Karen Wells; Brian K. Ahmedani; Rajesh Kumar; Esteban G. Burchard; Vimal K. Chowdhry; David Favro; David E. Lanfear; Manel Pladevall

BACKGROUND Asthma is an inflammatory condition often punctuated by episodic symptomatic worsening, and accordingly, patients with asthma might have waxing and waning adherence to controller therapy. OBJECTIVE We sought to measure changes in inhaled corticosteroid (ICS) adherence over time and to estimate the effect of this changing pattern of use on asthma exacerbations. METHODS ICS adherence was estimated from electronic prescription and fill information for 298 participants in the Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity. For each patient, we calculated a moving average of ICS adherence for each day of follow-up. Asthma exacerbations were defined as the need for oral corticosteroids, an asthma-related emergency department visit, or an asthma-related hospitalization. Proportional hazard models were used to assess the relationship between ICS medication adherence and asthma exacerbations. RESULTS Adherence to ICS medications began to increase before the first asthma exacerbation and continued afterward. Adherence was associated with a reduction in exacerbations but was only statistically significant among patients whose adherence was greater than 75% of the prescribed dose (hazard ratio, 0.61; 95% CI, 0.41-0.90) when compared with patients whose adherence was 25% or less. This pattern was largely confined to patients whose asthma was not well controlled initially. An estimated 24% of asthma exacerbations were attributable to ICS medication nonadherence. CONCLUSIONS ICS adherence varies in the time period leading up to and after an asthma exacerbation, and nonadherence likely contributes to a large number of these exacerbations. High levels of adherence are likely required to prevent these events.

Collaboration


Dive into the Esteban G. Burchard's collaboration.

Top Co-Authors

Avatar

Celeste Eng

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Donglei Hu

University of California

View shared research outputs
Top Co-Authors

Avatar

Sam S. Oh

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Scott Huntsman

University of California

View shared research outputs
Top Co-Authors

Avatar

Michael LeNoir

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge